Skin Manifestations in Pediatric Patients Treated With a TNF-Alpha Inhibitor for Inflammatory Bowel Disease: A Retrospective Study [Formula: see text].
María-Laura CossioAnnie GenoisPrévost JantchouAfshin HatamiColette DeslandresCatherine McCuaigPublished in: Journal of cutaneous medicine and surgery (2020)
This is one of the largest pediatric cohorts of IBD patients with CSEs. Psoriasiform eruptions were the most common CSEs, with predilection for skin folds and scalp, and frequent superimposed bacterial infection. Topical and/or systemic antibiotics were required in addition to topical corticosteroids in 25% of patients. The rate of discontinuation of anti-TNF therapy due to CSEs was low.
Keyphrases
- wound healing
- end stage renal disease
- rheumatoid arthritis
- ejection fraction
- newly diagnosed
- soft tissue
- chronic kidney disease
- peritoneal dialysis
- stem cells
- smoking cessation
- ulcerative colitis
- mesenchymal stem cells
- human milk
- young adults
- cell therapy
- patient reported
- replacement therapy
- preterm birth
- drug induced
- childhood cancer